Literature DB >> 11401180

Active transport of nitrofurantoin into human milk.

P M Gerk1, R J Kuhn, N S Desai, P J McNamara.   

Abstract

STUDY
OBJECTIVE: To determine the extent to which nitrofurantoin is transferred into human milk.
DESIGN: Prospective, single-dose pharmacokinetic study.
SETTING: University-affiliated clinical research center. PATIENTS: Four healthy lactating women 8-26 weeks postpartum. INTERVENTION: All subjects received a single, oral, 100-mg dose of nitrofurantoin macrocrystals with food. Serial serum and milk samples were obtained and analyzed by high-performance liquid chromatography.
MEASUREMENTS AND MAIN RESULTS: Milk pH, milk fat partitioning, and protein binding in serum and milk were determined. Predicted milk:serum ratio (M:S) was compared with the observed M:S. Nitrofurantoin M:S predicted was 0.28+/-0.05, whereas M:S observed was 6.21+/-2.71. Average milk concentration was 1.3 mg/L, and estimated suckling infant dosage was 0.2 mg/kg/day or 6% of maternal dose (mg/kg).
CONCLUSIONS: Nitrofurantoin is actively transported into human milk, achieving concentrations in milk greatly exceeding those in serum. Concern is warranted for suckling infants younger than 1 month old, or for infants with a high frequency of glucose-6-phosphate dehydrogenase deficiency or sensitivity to nitrofurantoin.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11401180     DOI: 10.1592/phco.21.7.669.34574

Source DB:  PubMed          Journal:  Pharmacotherapy        ISSN: 0277-0008            Impact factor:   4.705


  12 in total

Review 1.  Neonatal exposure to drugs in breast milk.

Authors:  Patrick J McNamara; Maggie Abbassi
Journal:  Pharm Res       Date:  2004-04       Impact factor: 4.200

2.  N-(4-[2-(1,2,3,4-tetrahydro-6,7-dimethoxy-2-isoquinolinyl)ethyl]-phenyl)-9,10-dihydro-5-methoxy-9-oxo-4-acridine carboxamide (GF120918) as a chemical ATP-binding cassette transporter family G member 2 (Abcg2) knockout model to study nitrofurantoin transfer into milk.

Authors:  Lipeng Wang; Markos Leggas; Mamta Goswami; Philip E Empey; Patrick J McNamara
Journal:  Drug Metab Dispos       Date:  2008-09-17       Impact factor: 3.922

Review 3.  Interaction of Isoflavones with the BCRP/ABCG2 Drug Transporter.

Authors:  Kristin M Bircsak; Lauren M Aleksunes
Journal:  Curr Drug Metab       Date:  2015       Impact factor: 3.731

4.  Using nitrofurantoin while breastfeeding a newborn.

Authors:  Jamie Zao; Gideon Koren; Pina Bozzo
Journal:  Can Fam Physician       Date:  2014-06       Impact factor: 3.275

5.  Molecular and functional identification of organic anion transporter isoforms in cultured bovine mammary epithelial cells (BME-UV).

Authors:  M M Al-Bataineh; D Van Der Merwe; B D Schultz; R Gehring
Journal:  J Vet Pharmacol Ther       Date:  2011-05-30       Impact factor: 1.786

6.  Prediction of Drug Transfer into Milk Considering Breast Cancer Resistance Protein (BCRP)-Mediated Transport.

Authors:  Naoki Ito; Kousei Ito; Yuki Ikebuchi; Yu Toyoda; Tappei Takada; Akihiro Hisaka; Akira Oka; Hiroshi Suzuki
Journal:  Pharm Res       Date:  2015-02-19       Impact factor: 4.200

7.  Acyclovir, ganciclovir, and zidovudine transfer into rat milk.

Authors:  Jane Alcorn; Patrick J McNamara
Journal:  Antimicrob Agents Chemother       Date:  2002-06       Impact factor: 5.191

8.  Sodium dependence of nitrofurantoin active transport across mammary epithelia and effects of dipyridamole, nucleosides, and nucleobases.

Authors:  Phillip M Gerk; Linda Hanson; Margaret C Neville; Patrick J McNamara
Journal:  Pharm Res       Date:  2002-03       Impact factor: 4.200

9.  Stereoselective interaction of pantoprazole with ABCG2. II. In vitro flux analysis.

Authors:  Lipeng Wang; Markos Leggas; Philip E Empey; Patrick J McNamara
Journal:  Drug Metab Dispos       Date:  2012-02-21       Impact factor: 3.922

10.  The ABCG2 C421A polymorphism does not affect oral nitrofurantoin pharmacokinetics in healthy Chinese male subjects.

Authors:  Kimberly K Adkison; Soniya S Vaidya; Daniel Y Lee; Seok Hwee Koo; Linghui Li; Amar A Mehta; Annette S Gross; Joseph W Polli; Yu Lou; Edmund J D Lee
Journal:  Br J Clin Pharmacol       Date:  2008-04-22       Impact factor: 4.335

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.